OSLO, Norway, June 10, 2025 /PRNewswire/ -- Reference is made to earlier communication by BlueNord ASA ("BlueNord" or the "Company") related to the Tyra Completion Test. Based on demonstrated achieved ...
Targeted interventions by patient characteristics to improve fecal immunochemical test completion could reduce disparities in colorectal cancer screening and improve overall compliance with screening ...
A test of the project's ability to perform as planned and generate the expected cash flows. After the completion test, the project can move from recourse to project financing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback